Geneos Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Sell |
2,380
-1,282
| -35% | -$106K | ﹤0.01% | 1002 |
|
|
2025
Q1 | $297K | Buy |
3,662
+2,471
| +207% | +$200K | ﹤0.01% | 1081 |
|
|
2024
Q4 | $107K | Sell |
1,191
-300
| -20% | -$27K | ﹤0.01% | 1046 |
|
|
2024
Q3 | $147K | Sell |
1,491
-50
| -3% | -$4.94K | 0.01% | 856 |
|
|
2024
Q2 | $143K | Hold |
1,541
| – | – | 0.01% | 786 |
|
|
2024
Q1 | $146K | Buy |
1,541
+145
| +10% | +$13.8K | 0.01% | 769 |
|
|
2023
Q4 | $125K | Sell |
1,396
-40
| -3% | -$3.57K | 0.01% | 780 |
|
|
2023
Q3 | $105K | Sell |
1,436
-350
| -20% | -$25.6K | 0.01% | 862 |
|
|
2023
Q2 | $149K | Sell |
1,786
-350
| -16% | -$29.1K | 0.01% | 758 |
|
|
2023
Q1 | $163K | Buy |
2,136
+12
| +0.6% | +$915 | 0.01% | 704 |
|
|
2022
Q4 | $176K | Hold |
2,124
| – | – | 0.01% | 664 |
|
|
2022
Q3 | $168K | Sell |
2,124
-1,150
| -35% | -$91K | 0.01% | 649 |
|
|
2022
Q2 | $250K | Buy |
3,274
+245
| +8% | +$18.7K | 0.01% | 671 |
|
|
2022
Q1 | $272K | Sell |
3,029
-2,750
| -48% | -$247K | 0.01% | 696 |
|
|
2021
Q4 | $647K | Sell |
5,779
-172
| -3% | -$19.3K | 0.02% | 505 |
|
|
2021
Q3 | $750K | Sell |
5,951
-300
| -5% | -$37.8K | 0.03% | 468 |
|
|
2021
Q2 | $853K | Sell |
6,251
-2,536
| -29% | -$346K | 0.03% | 410 |
|
|
2021
Q1 | $1.2M | Buy |
8,787
+304
| +4% | +$41.5K | 0.03% | 378 |
|
|
2020
Q4 | $874K | Buy |
8,483
+867
| +11% | +$89.3K | 0.04% | 387 |
|
|
2020
Q3 | $843K | Buy |
7,616
+31
| +0.4% | +$3.43K | 0.04% | 322 |
|
|
2020
Q2 | $837K | Buy |
7,585
+55
| +0.7% | +$6.07K | 0.05% | 311 |
|
|
2020
Q1 | $571K | Buy |
7,530
+456
| +6% | +$34.6K | 0.04% | 356 |
|
|
2019
Q4 | $680K | Sell |
7,074
-1,324
| -16% | -$127K | 0.04% | 380 |
|
|
2019
Q3 | $642K | Sell |
8,398
-632
| -7% | -$48.3K | 0.04% | 358 |
|
|
2019
Q2 | $792K | Buy |
9,030
+658
| +8% | +$57.7K | 0.05% | 318 |
|
|
2019
Q1 | $758K | Buy |
8,372
+1,124
| +16% | +$102K | 0.05% | 320 |
|
|
2018
Q4 | $508K | Sell |
7,248
-191
| -3% | -$13.4K | 0.04% | 369 |
|
|
2018
Q3 | $713K | Buy |
7,439
+439
| +6% | +$42.1K | 0.05% | 318 |
|
|
2018
Q2 | $666K | Hold |
7,000
| – | – | 0.05% | 279 |
|
|
2018
Q1 | $614K | Buy |
7,000
+511
| +8% | +$44.8K | 0.05% | 272 |
|
|
2017
Q4 | $550K | Sell |
6,489
-695
| -10% | -$58.9K | 0.05% | 297 |
|
|
2017
Q3 | $621K | Buy |
7,184
+237
| +3% | +$20.5K | 0.06% | 265 |
|
|
2017
Q2 | $536K | Buy |
6,947
+50
| +0.7% | +$3.86K | 0.06% | 278 |
|
|
2017
Q1 | $478K | Buy |
6,897
+600
| +10% | +$41.6K | 0.05% | 287 |
|
|
2016
Q4 | $372K | Buy |
6,297
+1,306
| +26% | +$77.2K | 0.05% | 315 |
|
|
2016
Q3 | $330K | Buy |
4,991
+86
| +2% | +$5.69K | 0.04% | 335 |
|
|
2016
Q2 | $273K | Sell |
4,905
-173
| -3% | -$9.63K | 0.04% | 368 |
|
|
2016
Q1 | $269K | Buy |
+5,078
| New | +$269K | 0.04% | 363 |
|